Yasser Mostafa Kamel | Charles Explorer

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

2023 | Publikace bez příslušnosti k fakultě